Skip to main content

BioLineRx Ltd.

BLRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001498403

No open-market purchases or sales by BioLineRx Ltd. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $206.7K in total; no superinvestor holds it.

Superinvestors holding BLRX, Q2 2026

See all superinvestors

No superinvestor reported holding BLRX in Q2 2026.

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of BLRX each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q1 2022

    0 superinvestors holding at quarter end

    Sold out
    ARK Invest
  2. Q4 2021

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−1.3%)
  3. Q3 2021

    1 superinvestor holding at quarter end

    New
    ARK Invest